Edition:
United Kingdom

Moleculin requests for clinical trial authorization to study annamycin


Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - Moleculin Biotech Inc ::Moleculin Biotech - ‍submitted request for clinical trial authorization to study annamycin for treating relapsed/refractory acute myeloid leukemia in Poland.